title: Neurologic Complications of Chronic Kidney Disease.
abstract: Chronic kidney disease (CKD) is an increasing problem worldwide and is now being recognized as a global health burden particularly for cardiovascular and cerebrovascular events. The incidence of stroke increases in the presence of CKD with a 3-fold increased rate reported in ESRD. Atrial fibrillation (AF) increases the risk of stroke in CKD. There is conflicting observational evidence regarding benefit of anticoagulation in CKD for prevention of stroke in AF as risk of bleeding is high. Overall, anticoagulant in CKD may be beneficial in appropriate patients with meticulous monitoring of international normalized ratio (INR). Neurological manifestations related to electrolyte disorders, drug toxicity, and uremia are common in CKD. Appropriate drug dosing, awareness of potential side effects of medications, prompt diagnosis, and treatment are essential in preventing long-term morbidity and mortality.
authors.affiliation: Department of Medicine, Division of Nephrology and Hypertension, Loyola University Medical Center, 2160 S. First Avenue, Bld 102 Room 3660, Maywood, IL, 60532, USA, kpotluri@lumc.edu.
authors.forename: Kavitha
authors.initials: K
authors.lastname: Vellanki
authors.forename: Vinod K
authors.initials: VK
authors.lastname: Bansal
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000209:etiology; D003072:Cognition Disorders / Q000209:etiology; D006801:Humans; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D020521:Stroke / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy
chemical_list: D000925:Anticoagulants